Q2 2021

Filed Aug 23, 2021 · 10-Q · 54 days after period end · 0001640334-21-002018

Q2 2021 · 10-Q

Revenue

$500.00K

— vs Q2 2020

Net Income

-$794.69K

N/M vs Q2 2020

EPS Diluted

-$0.02

— vs Q2 2020

Gross Profit$80,000—

Operating Income

Same quarter

Metric	Q2 2021	Q2 2020	Q2 2019	Q2 2017
Revenue	$500.00K	$0.00	$0.00	—
Net Income	-$794.69K	-$63.70K	-$50.82K	-$22.44K
EPS Diluted	-$0.02	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR